Back to company

IMMUNITRACK ApS: Financial statements 2020

CVR: 32347908

IMMUNITRACK ApS (CVR 32347908) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 1,089,608 and a net result of DKK -1,229,951 compared with DKK -2,303,315 the year before. Equity amounted to DKK 4,878,360. The solvency ratio was 67.2%. The company had 8 employees in the financial year.

Gross Profit
1,089,608 kr.
Profit/Loss
-1,229,951 kr.
Equity
4,878,360 kr.
Total Assets
7,256,548 kr.
Employees
8

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2020-1.1 mio.-1.2 mio.4.9 mio.8
2019--457 t.-2.3 mio.6.1 mio.6
2018-2.5 mio.1.7 mio.3.5 mio.4
2017-1 mio.239 t.288 t.-
2016-483 t.23 t.49 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is IMMUNITRACK ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2020

Stephen Clive Langford Gibbons joins the board of IMMUNITRACK ApSNov 1, 2020

As of November 1, 2020, Stephen Clive Langford Gibbons has joined the board of directors of IMMUNITRACK ApS.

About IMMUNITRACK ApS

IMMUNITRACK ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 2013. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 6 employees. In 2024, the company reported a gross profit of DKK 141,975,865 and a net result of DKK 110,009,470 compared with DKK -194,097 the year before. Equity amounted to DKK 21,211,816.